Peptide Vaccination in Treating Patients With Esophageal Cancer (STF-II)

Clinical trial NCT01267578 · UNKNOWN

Trial details

NCT number: NCT01267578
Sponsor: University of Yamanashi
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Cancer

Start date: 2010-04-01
Primary completion: 2011-05-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.